Table 1.
Source, (year), and location | Objective | Study design | Sample | Outcome measure |
Prevalence % (N) | Risk factorsa | Mean quality scoreb |
---|---|---|---|---|---|---|---|
Baldo et al. (2000) [29] Italy |
To evaluate the HCV prevalence in two groups of elderly people: nursing home and community-dwelling |
Cross-sectional | NH: 288 residents; mean age 84 from one NH Community: 208 subjects; mean age 73 from northeast Italy |
Anti-HCV | NH: 11.8 % (34/288) Community: 11.1 % (23/208) |
Age*, gender*, surgery, blood transfusion, dental therapy, household members with hepatitis, anti-HBs, and/or anti-HBc positivity* |
6 |
Chien et al. (1999) [14] USA |
To assess the prevalence of current or previous infection with viral hepatitis in an older NH population |
Prospective cohort | 199 residents; mean age 79 from 3 NHs |
Anti-HCV | 4.5 % (9/199) | Age, ethnicity, history of blood transfusion*, end stage renal disease, manual labor, previous surgeries, and injection drug use |
4 |
Floreani et al. (1992) [30] Italy |
To evaluate the prevalence of anti-HCV in a population of institutionalized older adults and to study the clinical features of anti-HCV positive subjects |
Cross-sectional | 315 residents; mean age 80 from one HFTA |
Anti-HCV | 2.2 % (7/315) | Blood transfusions, major surgery, length of institutionalization, and HBV serum markers |
3 |
Mansour-Ghanaei et al. (2007) [33] Iran |
To determine the frequency of HBV and HCV serological makers in residents of a Guilan NH |
Cross-sectional | 383 residents, mean age 58 from one NH |
Anti-HCVAb | 2.3 % (9/383) | Gender, short duration of residency in NH*, transfusion history, mental retardation, physically handicap, and history of surgery |
5 |
Maral et al. (2009) [31] Turkey |
The determine the seroprevalence of HBV and HCV in the elderly residing in two NHs |
Cross-sectional | 227 residents, mean age 76 from two NHs |
Anti-HCV IgG | 2.5 % (6/227) | Age, sex, and duration in NH | 4 |
Simor et al. (1992) [32] Canada |
To determine the prevalence of HBsAg, anti-HCV, and anti-HIV among residents of a LTC facility |
Cross-sectional | 508 residents, mean age 83 from one LTC facility |
Anti-HCV | 1.4 % (7/508) | Non | 6 |
Data on each risk-factor for each study was systematically determined and statistically tested for significance regarding anti-HCV positivity; significant risk factors identified in multivariate analysis are marked with an asterisk
Average quality score between the two reviewers using the modified tool; Score ranges from 0-7
Anti-HCV HCV antibody, HBV hepatitis B virus, HBsAg hepatitis B surface antigen, HBc anti-hepatitis B core antigen, HBs anti-hepatitis B surface antigen, HCV hepatitis C virus, HFTA home for the aged, HIV human immunodeficiency virus, LTC long-term care, NH nursing home